Excited to announce that David Strutton, Ph.D., a distinguished leader in healthcare policy, biopharmaceuticals, #vaccines, and #healtheconomics is joining Tufts-CEVR as a Senior Fellow.

Announcement here: cevr.tuftsmedicalcenter.org/news/david-s... @tuftscevr.bsky.social

New Tufts-CEVR paper in the J of Alzheimer's Disease, led by Paige Lin, provides updated health utility estimates for persons with AD and their caregivers across disease stages and settings.

journals.sagepub.com/doi/10.1177/... @tuftscevr.bsky.social @pattysynnott.bsky.social #Alzheimers

With @tuftscevr.bsky.social colleagues #ISPORAnnual in Montreal.

Thanks to all my wonderful Tufts-CEVR colleagues for putting on another great annual meeting! Proud to work with you!

@dano-hta.bsky.social @brianreid.bsky.social @tuftscevr.bsky.social @mollytoba.bsky.social

New study by my @tuftscevr.bsky.social colleague, Yolanda Zhu and colleagues.

The #IRA #Medicare Part D benefit redesign may significantly lower OOP drug spending for beneficiaries with #dementia and comorbidities.

tinyurl.com/5n8uxam3 #IRA #drugs

Good piece by @araymakers.bsky.social et al. using the Tufts CEA Registry:

"Concerns over CEAs identifying subgroups in their analyses do not appear to be justified & does not warrant precluding the use of #QALYs for decision-making or price negotiation for drugs."
@tuftscevr.bsky.social

The outlook for US payer coverage of specialty drugs in 2005.

Register here for our webinar, Dec 4, 3-3:30 ET:
tinyurl.com/2pndy8v8

Join us, Dec 4, 3-3:30 ET, as Tufts-CEVR's James Chambers discusses the outlook for US payer coverage of specialty drugs in 2025.

Register here: lnkd.in/g_GuE7bh.

Just back from #ISPOREurope in Barcelona, where I discussed dynamic pricing in economic evaluation with @dano-hta.bsky.social Mark Sculpher & Beth Woods.

(Also did some sightseeing with Sean Tunis.)

The final agenda for the 10/26 symposium in Boston, "Celebrating Cost-Effectiveness Analysis," is now available.

Register in person or online:
tinyurl.com/2ab38f9p